+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Alexion Pharmaceuticals - logo

Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare diseases. Alexion developed Soliris for the treatment of patients with paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. Soliris is approved in more than 50 countries for PNH and more than 40 countries for aHUS. Alexion's company headquarters are based Cheshire, Connecticut, United States.

From
Licensing Deals in Pharmaceuticals 2020-2025 - Product Thumbnail Image

Licensing Deals in Pharmaceuticals 2020-2025

  • Report
  • September 2025
  • 1000 Pages
  • Global
From
From
Hematology Collaboration and Licensing Deals 2016-2025 - Product Thumbnail Image

Hematology Collaboration and Licensing Deals 2016-2025

  • Report
  • October 2025
  • 150 Pages
  • Global
From
From
Treatment of PNH Market - Global Forecast 2025-2030 - Product Thumbnail Image

Treatment of PNH Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 194 Pages
  • Global
From
From
From
From
Collaboration Deals in Pharmaceuticals 2020-2025 - Product Thumbnail Image

Collaboration Deals in Pharmaceuticals 2020-2025

  • Report
  • September 2025
  • 950 Pages
  • Global
From
From
Antidotes Market Report 2025 - Product Thumbnail Image

Antidotes Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Morquio Syndrome Drugs - Global Strategic Business Report - Product Thumbnail Image

Morquio Syndrome Drugs - Global Strategic Business Report

  • Report
  • October 2025
  • 467 Pages
  • Global
From
Rare Diseases Treatment Market Report 2025 - Product Thumbnail Image

Rare Diseases Treatment Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
From
Nasal Drug Delivery Technology Market Report 2025 - Product Thumbnail Image

Nasal Drug Delivery Technology Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Rare Hematology - Global Strategic Business Report - Product Thumbnail Image

Rare Hematology - Global Strategic Business Report

  • Report
  • October 2025
  • 194 Pages
  • Global
From
Loading Indicator